Chen Y, Zhang J, Ge X, Du J, Deb DK, Li YC
There is no conclusive long-term human data, so it's recommended to use BPC-157 under the guidance of a healthcare provider
Paul KC, Zhang K, Walker DI, Sinsheimer J, Yu Y, Kusters C, et al
These bioactives, when loaded into nanocarriers like SLNs and NLCs, exhibit enhanced dermal penetration, stability, and controlled release profiles compared to crude extracts, making them more comparable mechanistically to synthetic small-molecule inhibitors
Immunohistochemistry analysis indicated that chemotherapy-resistant patients had significantly higher expression levels of NRF2, GPX4 and SOD1 in tumor tissues compared to the sensitive ones
doi: 10.1016/j.neuron.2017.02.022